Author:
Guns Pieter-Jan D.,Guth Brian D.,Braam Stefan,Kosmidis Georgios,Matsa Elena,Delaunois Annie,Gryshkova Vitalina,Bernasconi Sylvain,Knot Harm J.,Shemesh Yair,Chen Alon,Markert Michael,Fernández Miguel A.,Lombardi Damiano,Grandmont Céline,Cillero-Pastor Berta,Heeren Ron M.A.,Martinet Wim,Woolard Jeanette,Skinner Matt,Segers Vincent F.M.,Franssen Constantijn,Van Craenenbroeck Emeline M.,Volders Paul G.A.,Pauwelyn Thomas,Braeken Dries,Yanez Paz,Correll Krystle,Yang Xi,Prior Helen,Kismihók Gábor,De Meyer Guido R.Y.,Valentin Jean-Pierre
Funder
Horizon 2020 Framework Programme
Reference59 articles.
1. Prediction of human drug-induced liver injury (DILI) in relation to oral doses and blood concentrations;Albrecht;Archives of Toxicology,2019
2. A new paradigm for drug-induced torsadogenic risk assessment using human iPS cell-derived cardiomyocytes;Ando;Journal of Pharmacological and Toxicological Methods,2017
3. International Conference on Harmonisation; guidance on S7A safety pharmacology studies for human pharmaceuticals; availability. Notice;Anon;Federal Register,2001
4. International conference on harmonisation; guidance on S7B nonclinical evaluation of the potential for delayed ventricular repolarization (QT interval prolongation) by human pharmaceuticals; availability. Notice;Anon;Federal Register,2005
5. Anon, U.S. Food & Drug Administration, 2017, FDA's Predictive Toxiciology Roadmap, accessed June 2020.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献